Coya Therapeutics, Inc. (COYA) Misses Q2 EPS by 49c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q2 EPS of ($0.36), $0.49 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $163.62 thousand.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Northrop Grumman wins two U.S. defense contracts worth $38.7m
• 37 Capital raises $300,000 in partial private placement closing